ReviewBiomedicines2021

Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications.

Wenjing Zai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.